Cargando…
Antioxidants in disease mechanisms and therapy /
Antioxidants in Disease Mechanisms and Therapy presents molecular actions of natural and synthetic antioxidants and emphasizes the potential role in disease mechanisms and therapeutic strategies. The modulationof gene expression by the induction of antioxidant enzymes is a novel role beyond the dire...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
San Diego :
Academic Press,
�1997.
|
| Colección: | Advances in pharmacology (San Diego, Calif.) ;
38. |
| Temas: | |
| Acceso en línea: | Texto completo Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn371020133 | ||
| 003 | OCoLC | ||
| 005 | 20231117015311.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 090605s1997 caua ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e pn |c N$T |d OCLCQ |d UBY |d IDEBK |d E7B |d OCLCQ |d OPELS |d OCLCQ |d OCLCF |d OCLCO |d YDXCP |d EBLCP |d OCLCO |d OCLCQ |d ESU |d OCLCQ |d OCLCO |d OCLCQ |d D6H |d OTZ |d UAB |d LEAUB |d OCLCQ |d INARC |d OCLCA |d OCLCO |d OCLCQ | ||
| 019 | |a 505140612 |a 646757192 |a 808731439 |a 1164836298 | ||
| 020 | |a 9780080581309 |q (electronic bk.) | ||
| 020 | |a 0080581307 |q (electronic bk.) | ||
| 020 | |a 0120329395 |q (electronic bk.) | ||
| 020 | |a 9780120329397 |q (electronic bk.) | ||
| 035 | |a (OCoLC)371020133 |z (OCoLC)505140612 |z (OCoLC)646757192 |z (OCoLC)808731439 |z (OCoLC)1164836298 | ||
| 050 | 4 | |a RB170 |b .A586 1997eb | |
| 060 | 4 | |a W1 AD859 v.38 1997 | |
| 072 | 7 | |a MED |x 067000 |2 bisacsh | |
| 072 | 7 | |a MED |x 068000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.07 |2 22 |
| 245 | 0 | 0 | |a Antioxidants in disease mechanisms and therapy / |c edited by Helmut Sies. |
| 260 | |a San Diego : |b Academic Press, |c �1997. | ||
| 300 | |a 1 online resource (xxiii, 707 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Advances in pharmacology ; |v v. 38 | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record. | |
| 520 | |a Antioxidants in Disease Mechanisms and Therapy presents molecular actions of natural and synthetic antioxidants and emphasizes the potential role in disease mechanisms and therapeutic strategies. The modulationof gene expression by the induction of antioxidant enzymes is a novel role beyond the direct antioxidant action. The volume explores the current state of knowledge on oxidants and antioxidants in disease processes, including arteriosclerosis, adult respiratory distress syndrome, cystic fibrosis, Down's syndrome, inflammation, cataract, age-related macular degeneration, afflications of the nervous system, AIDS, liver diseases, diabetes, skin diseases, and cancer. Key Features * Contains cutting-edge information on focused topics written by expert scientists * Provides the first in-depth treatment of novel compounds, such as melatonin and polyamines * Attempts molecular pathophysiology which links basic science and the clinic * Presents critical assessment of controversial topics. | ||
| 505 | 0 | |a Front Cover; Antioxidants in Disease Mechanisms and Therapy; Copyright Page; Contents; Contributors; Preface; Part I: Natural Antioxidants; Chapter 1. Antioxidants: The Basics-What They Are and How to Evaluate Them; I. Introduction; II. Biologically Relevant ROS/RNS; III. Proving That a Putative Antioxidant Is Important in Vivo; References; Chapter 2. Metabolism of Vitamin C in Health and Disease; I. Introduction and Overview; II. Changes in Vitamin C Status Associated with Disease; III. Mechanism of Changes in Vitamin C Status Associated with Disease. | |
| 505 | 8 | |a IV. Evidence for Therapeutic Effectiveness of Vitamin CV. Significance and Conclusions; References; Chapter 3. Regulation of Human Plasma Vitamin E; I. Introduction; II. Plasma Kinetics; III. Discrimination between Tocopherols; IV. Genetic Studies; V. Conclusions; References; Chapter 4. Glutathione and Glutathione Delivery Compounds; I. Glutathione; II. Glutathione Delivery Compounds; III. Summary; References; Chapter 5. a-Lipoic Acid: A Metabolic Antioxidant and Potential Redox Modulator of Transcription; I. Introduction; II. Role of Lipoate in Metabolism; III. Antioxidant Properties. | |
| 505 | 8 | |a IV. NF-kB Role in Normal and Abnormal Cell FunctionReferences; Chapter 6. Antioxidant Actions of Melatonin; I. Introduction; II. Melatonin as a Free Radical Scavenger; III. Melatonin as an Antioxidant; IV. Effect of Melatonin on Enzymes Related to the Antioxidative Defense System; V. Concluding Remarks; References; Chapter 7. Antioxidative and Metal-Chelating Effects of Polyamines; I. Introduction; II. Chemistry and Type Reactions of Polyamines; III. Antioxidative Effects of Polyamines; IV. Conclusions; References; Chapter 8. Antioxidant and Chelating Properties of Flavonoids; I. Introduction. | |
| 505 | 8 | |a II. Free Radical-Scavenging, Antioxidant, and Chelatory Activities of FlavonoidsIII. Prooxidant Activity of Flavonoids; IV. Cytotoxic Effects of Flavonoids against Tumor Cells; V. Mutagenic and Antimutagenic Properties of Flavonoids; References; Part II: Synthetic Antioxidants and Enzyme Mimics; Chapter 1. Potential Use of Iron Chelators against Oxidative Damage; I. Introduction; II. Iron Homeostasis; III. Iron Release during Oxidative Stress; IV. Iron Chelators; V. Protective Effect of Iron Chelators against Oxidative Damage; VI. Concluding Remarks; References. | |
| 505 | 8 | |a Chapter 2. N-Acetylcysteine: Pharmacological Considerations and Experimental and Clinical ApplicationsI. Introduction; II. Biopharmaceutical and Pharmacological Aspects; III. General Biochemical and Cellular Effects; IV. Specific Therapeutic Effects of NAC in Animals and Humans; V. Summary; References; Chapter 3. Ebselen as a Glutathione Peroxidase Mimic and as a Scavenger of Peroxynitrite; I. Introduction; II. Synthesis of Ebselen; III. Molecular Activities of Ebselen; IV. Activity in Biological Model Systems; V. Metabolism; VI. Clinical Assessment; VII. Other Selenoorganic Compounds. | |
| 650 | 0 | |a Free radicals (Chemistry) |x Pathophysiology. | |
| 650 | 0 | |a Antioxidants |x Therapeutic use. | |
| 650 | 0 | |a Antioxidants |x Health aspects. | |
| 650 | 2 | |a Antioxidants |x pharmacology |0 (DNLM)D000975Q000494 | |
| 650 | 2 | |a Antioxidants |x therapeutic use |0 (DNLM)D000975Q000627 | |
| 650 | 6 | |a Radicaux libres (Chimie) |0 (CaQQLa)201-0023011 |x Physiopathologie. |0 (CaQQLa)201-0379296 | |
| 650 | 6 | |a Antioxydants |0 (CaQQLa)201-0102439 |x Emploi en th�erapeutique. |0 (CaQQLa)201-0373975 | |
| 650 | 6 | |a Antioxydants |0 (CaQQLa)201-0102439 |x Aspect sanitaire. |0 (CaQQLa)201-0374035 | |
| 650 | 7 | |a MEDICAL |x Pathology. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Pathophysiology. |2 bisacsh | |
| 650 | 7 | |a Antioxidants |x Health aspects. |2 fast |0 (OCoLC)fst00810644 | |
| 650 | 7 | |a Antioxidants |x Therapeutic use. |2 fast |0 (OCoLC)fst00810647 | |
| 650 | 7 | |a Free radicals (Chemistry) |x Pathophysiology. |2 fast |0 (OCoLC)fst00933920 | |
| 650 | 1 | 7 | |a Antioxidanten. |2 gtt |
| 700 | 1 | |a Sies, H. |q (Helmut), |d 1942- | |
| 776 | 0 | 8 | |i Print version: |t Antioxidants in disease mechanisms and therapy. |d San Diego : Academic Press, �1997 |z 0120329395 |z 9780120329397 |w (DLC) 96227565 |w (OCoLC)35842283 |
| 830 | 0 | |a Advances in pharmacology (San Diego, Calif.) ; |v 38. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780120329397 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/10543589/38 |z Texto completo |